ОРГАНОРІК

ਉਤਪਾਦ ਝਲਕ

About ORHANORIK

Orhanorik is intended for dopobetweennogo symptomatic treatment gostroi diarei in notmovliat aged from 3 months and children in combination with peroralnoiu regidratatheseieiu and zvychainymy duringtrymuvalnymy zakhodamy.

Iakthat etiotropnot treatment notmozhlyve, Orhanorik can zastosovuvaty as dopobetweennu terapiiu.

Composition

Active substance: rathiskadotryl; 1 sashe contains rathiskadotrylu 10 mg or 30 mg.

Excipients: sakharoza, silicon dioxide colloidal anhydrous, povidone.

Indications

Orhanorik is intended for the treatment of gostroi diarei in notmovliat aged from 3 months and children.

Pharmacological properties

Rathiskadotryl acts vykliuchno in slyzovii aboutolonthese intestine, reducing kyshkovu gipersekretheseiu vody and elektrolitiv.

It exerts shvydku abouttydiareinu action, not zminiuiuchy duration kyshkovogo twoundszytu.

Source: Compendium